| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Topper James N is a Director at NewAmsterdam Pharma Co N.V. with holdings across 3 companies. Recent SEC Form 4 filings include 14 buys and 0 sells.
Estimated insider holdings value: $126.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 660 | $23.70 | $15,638.90 | - | +46.6% | - | |
| Sep 8, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 1,260 | $24.99 | $31,487.40 | - | +42.5% | - | |
| Aug 11, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 471 | $23.98 | $11,293.97 | - | +59.9% | - | |
| Jun 25, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 3,780 | $18.38 | $69,466.07 | - | +45.5% | - | |
| Jun 16, 2025 | NAMS Newamsterdam Pharma Co N.V. | - | Buy | 8,584 | $19.50 | $167,381.13 | +0.3% | +22.1% | - | |
| May 21, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 3,780 | $3.86 | $14,609.32 | +6.8% | +166.2% | - | |
| May 14, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 7,420 | $3.30 | $24,462.49 | +7.6% | +219.4% | - | |
| May 12, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 48,203 | $3.17 | $152,916.63 | +69.9% | +226.3% | - | |
| Mar 26, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 1,135 | $22.49 | $25,520.59 | - | -18.4% | +38.5% | |
| Mar 4, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 4,005 | $21.02 | $84,203.12 | +0.1% | -12.0% | +45.0% |